Dec 11 2009
This year's Nobel Prize in Physiology or Medicine was awarded to
three American scientists Elizabeth Blackburn, Carol Greider and Jack
Szostak for the discovery of "how chromosomes are protected by telomeres
and the enzyme telomerase”. The research contributed to the
understanding of how telomeres protect chromosomes from degradation and
identified telomerase, the enzyme that preserves telomere length and
integrity.
Roughly speaking, telomeres are the tails of chromosomes; they are an
indicator of history and replicative potential of the cell. Research in
the last three decades indicates that telomeres are key factors in
several biological fields such as cancer and ageing. Because of the long
lifespan of humans and their short telomeres, attrition in telomere
length may be a major determinant of human ageing not only at cellular
level, but also at organ and perhaps systemic levels.
Recent studies, notably by the Nobel Prize winners have shown the
existence of a specific enzyme, telomerase, capable of restoring the
extremity of telomeres and thus keep the cell in “good shape”. Professor
Athanase BENETOS (Nancy, France), Member of the IAGG World Executive
Committee explains: “Results of recent clinical studies suggest that
subjects with shorter telomere length could have a more advanced
biological age and an increased predisposition for the development of
age-related diseases. These discoveries open new perspectives for the
detection and prevention of the risk of age-related diseases.”
A leap forward in Geriatric Medicine
“The ageing process remains a large domain of research and all
mechanisms are not depicted yet. These recent discoveries are a real
step forward to attract young scientist to the new fields of research
and clinical practice in Geriatric Medicine and Gerontology”, said
Professor Baeyens, President International Association of Gerontology
and Geriatrics (IAGG) for the European Region.
SOURCE International Association of Gerontology
and Geriatrics